ir.progenics.comInvestor Relations | Progenics Pharmaceuticals, Inc.
ir.progenics.com Profile
Ir.progenics.com is a subdomain of progenics.com, which was created on 1997-11-09,making it 27 years ago.
Description：The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial...
Discover ir.progenics.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.progenics.com Information
| HomePage size: 33.701 KB |
| Page Load Time: 0.211326 Seconds |
| Website IP Address: 184.50.88.76 |
ir.progenics.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
ir.progenics.com PopUrls
https://ir.progenics.com/index.php/static-files/0bc16099-bd2a-4d3d-8d8f-6520b1ec55ff |
https://ir.progenics.com/index.php/static-files/bd9440ff-ec6d-4b56-bb1b-f8e7aae3dc97 |
https://ir.progenics.com/index.php/static-files/1c50c91c-6014-45e9-9515-defd561a612b |
https://ir.progenics.com/index.php/static-files/7ad66c62-bb8f-4273-88e0-b6924ccc42d8 |
https://ir.progenics.com/index.php/static-files/71f28ace-a184-437f-b155-439748cc68dd |
https://ir.progenics.com/index.php/static-files/dcac6c8e-2d78-48be-a290-d69b6baec129 |
https://ir.progenics.com/index.php/static-files/a325d398-09a8-4fdd-a813-358cc488bf9b |
https://ir.progenics.com/index.php/static-files/825d5655-a52a-4829-be6e-be27bebad4bd |
https://ir.progenics.com/index.php/static-files/a40e0375-c231-497b-9158-8b6ddd5614c4 |
https://ir.progenics.com/index.php/static-files/9060c25a-3e38-4c6d-9353-a443731af2c8 |
https://ir.progenics.com/index.php/static-files/8cf46f93-3912-46c1-b428-935d6f7df423 |
https://ir.progenics.com/index.php/static-files/d8fda861-70e8-4b60-97ad-cb20a57afb55 |
https://ir.progenics.com/index.php/static-files/3dd089f7-5936-4307-9ea3-27fd03c8079f |
https://ir.progenics.com/index.php/static-files/035c570e-a22b-4beb-9f7f-c629860bb4d3 |
https://ir.progenics.com/index.php/static-files/5218c8f8-a9c5-45ca-a89e-b4538298728b |
https://ir.progenics.com/index.php/static-files/d6219a05-b7ff-424d-8f19-fa769638060d |
https://ir.progenics.com/index.php/static-files/880d9f7b-468a-45de-a444-afedfd72071f |
https://ir.progenics.com/index.php/static-files/a542fa8d-6791-4e6c-bf02-fa341fc0906f |
ir.progenics.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1592925121" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Tue, 23 Jun 2020 15:12:01 GMT |
| Link: http://ir.progenics.com/; rel="shortlink", http://ir.progenics.com/; rel="canonical", https://ir.progenics.com/investor-relations; rel="alternate"; hreflang="en", https://ir.progenics.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 1533 |
| X-Cache-Hits: 6 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-e3ab20dc-b563-11ea-881d-47e3a54c8f36 |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 9101 |
| X-EdgeConnect-MidMile-RTT: 46, 46 |
| X-EdgeConnect-Origin-MEX-Latency: 32, 32 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Tue, 23 Jun 2020 15:37:35 GMT |
| Date: Tue, 23 Jun 2020 15:37:35 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
ir.progenics.com Meta Info
| charset="utf-8"/ |
| content="Progenics Pharmaceuticals, Inc." property="og:site_name"/ |
| content="noindex, nofollow" name="robots"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="https://ir.progenics.com/investor-relations" property="og:url"/ |
| content="Investor Relations | Progenics Pharmaceuticals, Inc." property="og:title"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about Progenics Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="width=device-width, initial-scale=0.382" name="viewport"/ |
ir.progenics.com Ip Information
| Ip Country: United States |
| City Name: San Jose |
| Latitude: 37.1835 |
| Longitude: -121.7714 |
ir.progenics.com Html To Plain Text
Progenics Pharmaceuticals, Inc. is now a subsidiary of Lantheus Holdings, Inc. 646-975-2500 Contact Us Pipeline Approved Products AZEDRA – Ultra-Orphan Radiotherapeutic In Development PyL – PSMA Targeted PET Imaging Agent 1404 – PSMA Targeted Imaging 1095 – Small Molecule Therapeutic Clinical Trials Investors Investors Overview Proxy Materials Financial Information/Reports SEC Filings Quarterly Results Press Releases Business Development Overview Become A PartnerVision Management Team Board of Directors Compliance Program Careers Contact Us Investors Investor Relations Overview Proxy Materials Financial Information/Reports MORE Investor Relations Investor Relations Progenics is proud to have joined the Lantheus family. Lantheus, a global leader in the field of medical imaging, develops, manufactures and commercializes essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. These pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography and nuclear imaging. We are pleased to add three commercial products and a pipeline of therapeutic agents and PSMA-targeted imaging agents to the Lantheus portfolio. To learn more about investor relations, please click here . View all » Recent Releases Jun 22, 2020 Summary Toggle Lantheus Completes Merger with Progenics Jun 16, 2020 Summary Toggle Progenics Stockholders Approve Merger with Lantheus Contact Us Privacy Policy Legal Notice Compliance Trademarks, registered or otherwise, are the property of their respective owner. © 2020 Lantheus Holdings, Inc. All rights reserved. Intended for U.S. Residents only. 331 Treble Cove Road, N. Billerica, MA 01862 Telephone: 1-800-362-2668 Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy...
ir.progenics.com Whois
Domain Name: PROGENICS.COM Registry Domain ID: 616797_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-09-08T15:15:50Z Creation Date: 1997-11-09T05:00:00Z Registry Expiry Date: 2024-11-08T05:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.HVDATA.NET Name Server: NS2.HVDATA.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:30:34Z <<<